![Geng Sheng Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Geng Sheng Yang
Director/Board Member at XinYu Pharmaceutical Co., Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pei Jian Wang | M | 45 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 5 years |
Xin Hua Meng | M | 70 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 34 years |
Xiao Run Chang | M | 58 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 9 years |
Hui Ping Wu | M | 52 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 8 years |
Xiao Fei Wan | M | 58 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 25 years |
Li Yuan Zhu | M | 59 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 36 years |
Li Li | M | 58 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 36 years |
Rui Hua Liu | M | 54 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 32 years |
Yu Meng | F | 34 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 9 years |
Hai Jun Chen | M | 48 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 25 years |
Cui Ling Zhao | F | 53 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 31 years |
Liang Dong | M | 48 |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | 27 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Xiang Zhao Li | M | - |
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | - |
Jian Guo Gu | M | 61 |
Zhejiang University of Technology
| 4 years |
Tian Zhu Dai | M | 70 |
Zhejiang University of Technology
| 4 years |
Gang Min Huang | M | 57 |
Zhejiang University of Technology
| 4 years |
Min Chu | M | 59 |
Zhejiang University of Technology
| 4 years |
Tianfeng Wang | F | 60 |
Zhejiang University of Technology
| 4 years |
Cheng Wei Zhang | M | 64 |
Zhejiang University of Technology
| 4 years |
Wen Xue Xu | M | 59 |
Zhejiang University of Technology
| 4 years |
Bu Fei Chen | M | 64 |
Zhejiang University of Technology
| 2 years |
Yan He Xu | M | 66 |
Zhejiang University of Technology
| 4 years |
Jian Xiong Shao | M | 60 |
Zhejiang University of Technology
| 4 years |
Ming Chuan Ren | M | 64 |
Zhejiang University of Technology
| 10 years |
Li Jian | M | 65 |
Zhejiang University of Technology
| 4 years |
Xiao Feng Yu | M | 60 |
Zhejiang University of Technology
| 4 years |
Yin Jian Wang | M | - |
Zhejiang University of Technology
| 4 years |
Shu Zhong Mao | M | 62 |
Zhejiang University of Technology
| 4 years |
Cai Liang Shou | M | 63 |
Zhejiang University of Technology
| 4 years |
Lei Yu | M | 61 |
Zhejiang University of Technology
| 4 years |
Bing Zhu | M | 59 |
Zhejiang University of Technology
| 4 years |
Xin An Zhang | F | 59 |
Zhejiang University of Technology
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 32 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Geng Sheng Yang
- Personal Network